Large-scale testing (Phase 3)Study completedNCT04964089
What this trial is testing
Evaluate the Efficacy and Safety of Intravitreal KSI-301 Compared With Intravitreal Aflibercept in Participants With Neovascular (Wet) Age-related Macular Degeneration (wAMD)
Who this might be right for
Wet Age-related Macular Degeneration
Kodiak Sciences Inc 557